glp-1 for teens Teens: Safety, Age Limits & Biomarker Context – PlexusDx Use of GLP-1 weight-loss drugs
Description
It is accessible, easy to see, and offers plenty of real estate to rotate your spots
Documentation indicates that the prescription aims to reduce cardiovascular risk, not promote weight loss
Gastrointestinal side effects of high-dose GLP-1 RAs and co-agonists occurred in 30% ~ 70% of patients, mostly arising within the first 2 weeks of the first dose, being mild or moderate in severity, and transient [40]
The fact that GLP-1 strongly inhibits glucagon secretion in individuals with type 1 diabetes [50,51,52] nevertheless suggests that other mechanisms are needed to fully account for the modulatory effect of GLP-1 on glucagon secretion
National Research Council
